Vaxxinity Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
DALLAS, Dec. 23, 2021 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new…
Pharmaceuticals, Biotechnology and Life Sciences
DALLAS, Dec. 23, 2021 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new…
– Well-established finance professional with over 20 years of experience gained in pharmaceutical, biopharma and professional services sectors TORONTO, ONTARIO,…
FLORHAM PARK, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel…
VLN® Cigarettes VLN® King & VLN® Menthol King VLN® Is World’s First and Only Combustible Cigarette to Receive FDA MRTP…
Saint Herblain (France), December 23, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…
New website (www.Rethink-ALZ.com) is intended to increase visibility and information for potential study participants.Rethink-ALZ.com connects patients with nearest participating clinical…
FDA approved the removal of the boxed warning from the TYMLOS label, effective December 22, 2021The boxed warning had referred…
– Topline results from pivotal SEAL study expected in Q1 2022 – If approved, ADAIR will target the growing Adderall®…
Researchers around the world can utilize the synthetic genome to produce virus to test strain-specific diagnostics, monoclonal antibody treatments, small-molecule…
WESTLAKE VILLAGE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing…